Fennec Pharmaceuticals Stock Market Value
| FENC Stock | USD 5.66 0.34 6.39% |
| Symbol | Fennec |
Fennec Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 1.814 | Quarterly Revenue Growth 0.07 | Return On Assets 0.027 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fennec Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fennec Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fennec Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Fennec Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Fennec Pharmaceuticals or generate 0.0% return on investment in Fennec Pharmaceuticals over 30 days. Fennec Pharmaceuticals is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company More
Fennec Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fennec Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fennec Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.01 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 23.48 | |||
| Value At Risk | (6.68) | |||
| Potential Upside | 7.14 |
Fennec Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fennec Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fennec Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Fennec Pharmaceuticals historical prices to predict the future Fennec Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0151 | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.64) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.017 |
Fennec Pharmaceuticals Backtested Returns
At this point, Fennec Pharmaceuticals is slightly risky. Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0357, which denotes the company had a 0.0357% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Fennec Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Fennec Pharmaceuticals' Downside Deviation of 4.01, coefficient of variation of 11116.55, and Mean Deviation of 3.11 to check if the risk estimate we provide is consistent with the expected return of 0.16%. Fennec Pharmaceuticals has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.67, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fennec Pharmaceuticals will likely underperform. Fennec Pharmaceuticals right now shows a risk of 4.35%. Please confirm Fennec Pharmaceuticals total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Fennec Pharmaceuticals will be following its price patterns.
Auto-correlation | -0.48 |
Modest reverse predictability
Fennec Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between Fennec Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fennec Pharmaceuticals price movement. The serial correlation of -0.48 indicates that about 48.0% of current Fennec Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Fennec Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Fennec Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fennec Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Fennec Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Fennec Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Fennec Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fennec Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fennec Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fennec Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Fennec Pharmaceuticals Lagged Returns
When evaluating Fennec Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fennec Pharmaceuticals stock have on its future price. Fennec Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fennec Pharmaceuticals autocorrelation shows the relationship between Fennec Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Fennec Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Fennec Pharmaceuticals Correlation, Fennec Pharmaceuticals Volatility and Fennec Pharmaceuticals Alpha and Beta module to complement your research on Fennec Pharmaceuticals. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.